← Back to Search

Dexamethasone for Chronic Sinusitis

Phase 4
Waitlist Available
Led By Luke Rudmik, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

Dexamethasone added to sinufoam, which is placed in the ethmoid cavity at the completion of endoscopic sinus surgery, will improve sinonasal mucosal healing.

Eligible Conditions
  • Chronic Sinusitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: DexamethasoneActive Control1 Intervention
Sinufoam is mixed with dexamethasone and placed within the ethmoid cavity at the completion of sinus surgery
Group II: SalinePlacebo Group1 Intervention
Sinufoam is mixed with saline and placed within the ethmoid cavity at the completion of sinus surgery

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
805 Previous Clinical Trials
883,992 Total Patients Enrolled
2 Trials studying Chronic Sinusitis
154 Patients Enrolled for Chronic Sinusitis
Luke Rudmik, MDPrincipal InvestigatorUniversity of Calgary
2 Previous Clinical Trials
130 Total Patients Enrolled
~3 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top